• Home
• About us
• Our management
• Board of Directors

Board of Directors

The Board of Directors is responsible for our company's corporate governance and ultimately accountable for our activities, strategy and performance.

The Chief Executive Officer is responsible for the management of the business and is assisted by the Corporate Executive Team.

Sir Christopher Gent - Non-Executive Chairman

Sir Christopher Gent is Non-Executive Chairman of GlaxoSmithKline plc. He also serves as Chairman of the Nominations and Corporate Responsibility Committees.
Find out more about Sir Christopher Gent

Andrew Witty - Chief Executive Officer

Andrew Witty is Chief Executive Officer of GlaxoSmithKline. He assumed this role in May 2008 after being appointed to the the Board in January 2008.
Find out more about Andrew Witty

Professor Sir Roy Anderson - Non-Executive Director

Professor Sir Roy Anderson is the Professor of Infectious Disease Epidemiology in the Faculty of Medicine, Imperial College, London.
Find out more about Roy Anderson

Dr Stephanie Burns - Non-Executive Director

Dr Stephanie Burns is Chairman, president and chief executive officer of Dow Corning.
Find out more about Stephanie Burns

Lawrence Culp - Non-Executive Director

Lawrence Culp is President and Chief Executive Officer of Danaher Corporation. Prior to joining Danaher, he held positions in Accenture, previously Andersen Consulting.
Find out more about Lawrence Culp

Sir Crispin Davis - Non-Executive Director

Sir Crispin Davis is an Independent Non-Executive Director and Chief Executive of Reed Elsevier plc.
Find out more about Sir Crispin Davis

Julian Heslop - Chief Financial Officer

Julian Heslop assumed the role of Chief Financial Officer for GlaxoSmithKline in April 2005.
Find out more about Julian Heslop

Sir Deryck Maughan - Non-Executive Director

Sir Deryck Maughan is an Independent Non-Executive Director and the Managing Director of Kohlberg Kravis Roberts and Co. (KKR) and Chairman of KKR Asia.
Find out more about Sir Deryck Maughan

Dr Daniel Podolsky - Non-Executive Director

Dr Daniel Podolsky is an Independent Non-Executive Director and is Chief of Gastroenterology at Massachusetts General Hospital and Harvard Medical School.
Find out more about Dr Daniel Podolsky

Sir Ian Prosser - Senior Independent Non-Executive Director

Sir Ian Prosser was a Non-Executive Director of SmithKline Beecham plc from 1st August 1999 until the completion of the merger with Glaxo Wellcome plc in December 2000.
Find out more about Sir Ian Prosser

Dr Ronaldo Schmitz - Non-Executive Director

Dr Ronald Schmitz is an Independent Non-Executive Director.
Find out more about Dr Ronald Schmitz

Moncef Slaoui - Chairman, Research & Development

Moncef Slaoui assumed the role of Chairman, Research & Development, GlaxoSmithKline, in June 2006.
Find out more about Moncef Slaoui

Tom de Swaan - Non-Executive Director

Tom de Swaan is an Independent Non-Executive Director and Chairman, Audit Committee.
Find out more about Tom de Swaan

Chris Viehbacher

Chris Viehbacher resigned from the Board on 8 September 2008 and will leave the company on 1 December 2008.

Sir Robert Wilson - Non-Executive Director

Sir Robert Wilson is Non-Executive Chairman of BG Group plc and the Economist Group and was previously Executive Chairman of Rio Tinto plc.
Find out more about Sir Robert Wilson